The results indicated that the probability of liver cirrhosis patients progressing to hepatocellular carcinoma was 0.0749 (7.5%) when AT3 levels were normal, 0.0709 (7.1%) when AT3 was low, and 0.0850 (8.5%) when AT3 was high. This evidence concerns the gene SERPINC1 and cirrhosis of liver.